High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization

Human Reproduction

Volumn 13, Issue 3, 1998, Pages 573-575

  De Jong, D ^a   Macklon, N S ^a   Mannaerts, B M J L ^b   Coelingh Bennink, H J T ^b   Fauser, B C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NV ORGANON   (Netherlands)

Author keywords

GnRH antagonists; Imminent ovarian hyperstimulation syndrome; In vitro fertilization; Ovarian hyperstimulation syndrome

Indexed keywords

ESTRADIOL; GANIRELIX; GONADORELIN ANTAGONIST; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CASE REPORT; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVULATION INDUCTION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031896451     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.3.573     Document Type: Article

References (19)

1. Albano, C., Smitz, J., Camus, M. et al. (1996) Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone. Hum. Reprod., 11, 2114-2118.
2. Albano, C., Smitz, J., Camus, M. et al. (1997) Comparison of different doses of gonadotrophin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil. Steril., 67, 917-922.
3. Diedrich, K., Diedrich, C., Santos, E. et al. (1994) Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum. Reprod., 9, 788-791.
4. Ditkoff, E.C., Cassidenti, D.L., Paulson, R.J. et al. (1991) The gonadotropin-releasing hormone antagonist (NaI-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women. Am. J. Obstet. Gynecol., 165, 1811-1817.
5. Donderwinkel, P.F., School, D.C., Pache, T.D. et al. (1993) Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist. Hum. Reprod., 8, 2027-2032.
6. Dubourdieu, S., Charbonnel, B., D'Acremont, M.F. et al. (1994) Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH. J. Clin. Endocrinol. Metab., 78, 343-347.
7. Felberbaum, R., Reissmann, T., Küpker, W. et al. (1996) Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist cetrorelix at different dosages. J. Assist. Reprod. Genet., 13, 216-222.
8. Gordon, K., Williams, R.F., Danforth, D.R. and Hodgen, G.D. (1990) A novel regimen of gonadotropin-releasing hormone (GnRH) antagonist plus pulsatile GnRH: controlled restoration of gonadotropin secretion and ovulation induction. Fertil. Steril., 54, 1140-1145.
9. Klingmüller, D., Schepke, M., Enzweiler, C. and Bidlingmaier, F. (1993) Hormonal response to the new potent GnRH-antagonist Cetrorelix. Acta Endocrinol., 128, 15-18.
10. Latouche, J., Crumeyrolle-Arias, M., Jordan, D. et al. (1989) GnRH receptors in human granulosa cells: anatomical localization by autoradiographic study. Endocrinology, 125, 1739-1741.
11. Minaretzis, D., Jakubowski, M., Mortola, J.F. and Pavlou, S.N. (1995) Gonadotropin-releasing hormone receptor gene expression in the human ovary and granulosa-lutein cells. J. Clin. Endocrinol. Metab., 80, 430-434.
12. Nelson, L.R., Fujimoto, V.Y., Jaffe, R.B. and Monroe, S.E. (1995) Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix). Fertil. Steril., 63, 963-969.
13. Olivennes, F., Fachin, R., Bouchard, P. et al. (1994) The single and dual administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in an in-vitro fertilization-embryo transfer program. Fertil. Steril., 62, 468-476.
14. Pellicer, A. and Miro, F. (1990) Steroidogenesis in vitro of human granulosaluteal cells pretreated in vivo with gonadotropin-releasing hormone analogs. Fertil. Steril., 54, 590-596.
15. Pinski, J., Lamharzi, N., Halmos, G. et al. (1996) Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist Cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats. Endocrinology, 137, 3430-3436.
16. Rizk, B. and Aboulghar, M. (1991) Modern management of ovarian hyperstimulation syndrome. Hum. Reprod., 6, 1082-1087.
17. Schenker, J.G. and Weinstein, D. (1978) Ovarian hyperstimulation syndrome: a current survey. Fertil. Steril., 30, 255-268.
18. Ubaldi, F., Albano, C., Peukert, M. et al. (1996) Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles. Hum. Reprod., 11, 1405-1407.
19. Wada, I., Matson, P.L., Horne, G. et al. (1992) Is continuation of gonadotrophin-releasing hormone agonist (GnRHa) necessary for women at risk of developing the ovarian hyperstimulation syndrome? Hum. Reprod., 7, 1090-1093.